Multi-omics Analysis of Immune Determinants of STK11 in Non-Small Cell Lung Cancer

被引：0
|
作者：
Alhushki, S. K. [1 ]
Al-Muhtaseb, A. [2 ]
Abushukair, H. [3 ]
Abulrous, F. [4 ]
机构：
[1] Mutah Univ, Al Karak, Jordan
[2] Hashemite Univ, Zarqa, Jordan
[3] Jordan Univ Sci & Technol, Irbid, Jordan
[4] Henry Ford Hlth, Detroit, MI USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
STK11; Immunotherapy; Non-small Cell Lung Cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP03.03-02
引用
收藏
页码：S442 / S443
页数：2
相关论文
共 50 条
  • [1] STK11 is a Potential Therapeutic and Prognostic Biomarker and Correlates with Immune Infiltrates in Non-Small Cell Lung Cancer
    Bensalim, Imane
    Boustany, Youssra
    El Faqer, Abdelmoiz
    Laraqui, Abdelilah
    Belkadi, Bouchra
    EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2024, 8 (03): : 358 - 370
  • [2] Role of STK11 in ALK-positive non-small cell lung cancer
    Zhou, Wen
    Yan, Lu-Da
    Yu, Zhi-Qiong
    Li, Na
    Yang, Yong-Hua
    Wang, Meng
    Chen, Yuan-Yuan
    Mao, Meng-Xia
    Peng, Xiao-Chun
    Cai, Jun
    ONCOLOGY LETTERS, 2022, 23 (06)
  • [3] STK11/LKB1 mutation in non-small cell lung cancer: Prognostic or predictive?
    Rosellini, P.
    Girodet, P. O.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 50 - 51
  • [4] Multi-omics analysis reveals the sensitivity of immunotherapy for unresectable non-small cell lung cancer
    Wu, Rui
    Wei, Kunchen
    Huang, Xingshuai
    Zhou, Yinge
    Feng, Xiao
    Dong, Xin
    Tang, Hao
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [5] Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer
    Rosellini, Pietro
    Amintas, Samuel
    Caumont, Charline
    Veillon, Remi
    Galland-Girodet, Sigolene
    Cuguilliere, Alain
    Nguyen, Laurent
    Domblides, Charlotte
    Gouverneur, Amandine
    Merlio, Jean-Philippe
    Bezin, Julien
    Girodet, Pierre-Olivier
    EUROPEAN JOURNAL OF CANCER, 2022, 172 : 85 - 95
  • [6] Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation
    An, Josiah
    Yan, Melissa
    Yu, Nanmeng
    Chennamadhavuni, Adithya
    Furqan, Muhammad
    Mott, Sarah L.
    Loeffler, Bradley T.
    Kruser, Timothy
    Sita, Timothy L.
    Feldman, Lawrence
    Nguyen, Ryan
    Pasquinelli, Mary
    Hanna, Nasser H.
    Abu Hejleh, Taher
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (08) : 3608 - 3615
  • [7] LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value
    Facchinetti, Francesco
    Bluthgen, Maria Virginia
    Tergemina-Clain, Gabrielle
    Faivre, Laura
    Pignon, Jean-Pierre
    Planchard, David
    Remon, Jordi
    Soria, Jean-Charles
    Lacroix, Ludovic
    Besse, Benjamin
    LUNG CANCER, 2017, 112 : 62 - 68
  • [8] The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas
    Mograbi, Baharia
    Heeke, Simon
    Hofman, Paul
    DIAGNOSTICS, 2021, 11 (02)
  • [9] Role of the “inflammation-immunity-metabolism” network in non-small cell lung cancer: a multi-omics analysis
    Jingqi Zhang
    Liping Lin
    Wenyuan Li
    Jing Guo
    Discover Oncology, 16 (1)
  • [10] Multi-omics and artificial intelligence predict clinical outcomes of immunotherapy in non-small cell lung cancer patients
    Mei, Ting
    Wang, Ting
    Zhou, Qinghua
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
12345